PER
Click for more information
1.27% 8.0¢ percheron therapeutics limited

ATL1103 Successfully Progresses Towards Phase II Clinical...

  1. Trade4Profit88
    10,465 Posts.
    lightbulb Created with Sketch. 735
    clock Created with Sketch.
    07/12/11
    10:00
    Post #: 9402583
    ATL1103 Successfully Progresses Towards Phase II Clinical Trial

    ATL1103 Phase I trial successfully meets primary endpoint – safe and well
    tolerated
    ? Preliminary indication of drug activity shown with reduction of serum IGF-I
    and other markers of drug activity
    ? Next step is a Phase II trial in patients with the growth disorder,
    acromegaly
    ANP Price at posting: 32.0¢ Sentiment: ST Buy Disclosure: Held
    Likes Created with Sketch. 7  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Bitcoin hits all-time high as markets predict Trump victory: Join Discussion here!
right-arrow Created with Sketch.
NEWS Trump is President Again: What Does This Mean for Crypto?
right-arrow Created with Sketch.
NEWS Imugene kicks off Australian trial for blood cancer treatment
right-arrow Created with Sketch.
EQN Equinox Resources reports outstanding naturally occurring antimony grade at Alturas Project
right-arrow Created with Sketch.
NEWS Update on the ASX' most anticipated drill campaign
right-arrow Created with Sketch.
RMX Red Mountain Mining (ASX:RMX) announces Bonanza Grade Gold Results at Flicka Lake
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢ 		Change
0.001(1.27%) 		Mkt cap ! $82.94M
Open High Low Value Volume
8.0¢ 8.3¢ 7.9¢ $461.5K 5.711M

Buyers (Bids)

No. Vol. Price($)
6 844186 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 292500 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.